Signal Advisors Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
11,191
+2,647
+31% +$2.7M 0.68% 33
2026
Q1
$7.86M Buy
8,544
+2,309
+37% +$2.34M 0.54% 41
2025
Q4
$6.7M Buy
6,235
+824
+15% +$788K 0.53% 46
2025
Q3
$4.13M Buy
5,411
+1,338
+33% +$996K 0.37% 65
2025
Q2
$3.17M Buy
4,073
+3,166
+349% +$2.46M 0.25% 101
2025
Q1
$749K Sell
907
-8
-0.9% -$6.66K 0.07% 224
2024
Q4
$707K Buy
915
+14
+2% +$11.6K 0.08% 220
2024
Q3
$798K Buy
901
+573
+175% +$515K 0.11% 195
2024
Q2
$297K Sell
328
-685
-68% -$548K 0.65% 46
2024
Q1
$788K Buy
1,013
+188
+23% +$134K 0.2% 115
2023
Q4
$481K Buy
+825
New +$482K 0.17% 121

Other funds holding LLY

Signal Advisors Wealth's LLY Position: Q2 2026 in Review

Signal Advisors Wealth increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $2.7M and bringing the position to 11,191 shares worth $13.4M. The position accounts for 0.68% of the portfolio, ranked #33.

Signal Advisors Wealth first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signal Advisors Wealth held 11,191 shares of Eli Lilly worth $13.4M as of Q2 2026.
  • Signal Advisors Wealth bought 2,647 Eli Lilly shares in Q2 2026, an estimated $2.7M.
  • Eli Lilly made up 0.68% of Signal Advisors Wealth's portfolio in Q2 2026, its #33 holding.
  • Signal Advisors Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.